Wallace, Youngmin A. Lee, Luke A. Noon, Kemal M. Akat, Marie-Luise Berres Background: Hepatitis C virus nonstructural protein 5A (HCV NS5A) plays a role in HCV replication and hepatocarcinogenesis. MG132 is a specific proteasome inhibitor, which blocks ubiquitin-degradation pathway. MG132 also activates c-JUN N-terminal kinase (JNK1), which can induce apoptosis, and also inhibits nuclear factor kappa B (NF-κB) activation. It has been reported

that HCV NS5A protein can activate NF-κB pathways. In the present study, we examined whether HCV NS5A could block apoptosis induced by MG132 in hepato-cytes. Methods: We cloned the different Hydroxychloroquine price HCV genotype 1b NS5A-coding regions, having wide-type, intermediatetype, or mutant-type of interferon sensitivity determining region (ISDR), into the mammalian cell protein expression plasmids. These vectors

were transfected into HepG2 Fulvestrant supplier cells and each HepG2-NS5A cell lines were established after G418 treatment. These cells were incubated with 1 – 10 μM MG132 for 6 – 48 hours. Cell death and apoptosis were evaluated by crystal violet stain and Apopercentage assay, respectively. Translocation to the nuclei of NF-kB p65 and poly ADP-ribose polymerase (PARP) cleavage were also examined by confocal microscopy and Western blotting, respectively. Results: We observed the different

cell viability treated Digestive enzyme by MG132 between HepG2-HCV NS5A and HepG2-control cells. HCV NS5A significantly reduced MG1 32-induced apoptosis, (9.2% vs. 42%, P<0.05, n=3) by Apopercentage assay and also blocked PARP cleavage, compared with HepG2-control. The nuclear translocation of NF-κB p65 was significantly inhibited after MG132 treatment in HepG2-control, compared with HepG2-NS5A (21.7±2.03 vs. 1.7±0.58, P<0.05, n=3). However, we observed no differences of apoptosis among HepG2-NS5A having different amino acid substitutions in ISDR. Conclusion: Apoptosis of hepatocytes induced by MG132 was blocked by HCV NS5A through the suppression of nuclear translocation of NF-κB p65. HCV NS5A ISDR was not involved in this mechanism. Our results indicate that HCV NS5A might interact with proteasome ubiquitin-degradation pathway and shed new light on the study of HCV replication and HCV-associated hepato-carcinogenesis. Disclosures: Tatsuo Kanda – Speaking and Teaching: MSD K.K., AJINOMOTO PHARMACEUTICALS CO., LTD, CHUGAI PHARMACEUTICAL CO.